Pharmaceuticals · medium ·
Pharmaceutical Commercialisation Adopting AI-Native Operating Layers and Privacy-in-Production Architectures
The pharmaceutical sector is transitioning from generic AI tools to AI-native operating layers for commercialisation. These platforms are designed from the ground up with 'privacy-in-production' and in-situ training within regulated environments, leading to a consolidation of commercial value in unified, compliant systems that seamlessly integrate data, content, and omnichannel delivery.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.